Individuals with T1D depend on external insulin treatment to maintain their blood glucose levels within an appropriate range, preventing or reducing the risk of acute complications such as diabetic ketoacidosis (DKA), severe hypoglycemia, and chronic vascular complications associated with diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.